Choroid Plexus Epithelial Cells in Neurodegeneration

Choroid Plexus Epithelial Cells in Neurodegeneration

<table class="infobox infobox-cell">
<tr>
<th class="infobox-header" colspan="2">Choroid Plexus Epithelial Cells in Neurodegeneration</th>
</tr>
<tr>
<td class="label">Taxonomy</td>
<td>ID</td>
</tr>
<tr>
<td class="label">Cell Ontology (CL)</td>
<td>[CL:0000706](https://www.ebi.ac.uk/ols4/ontologies/cl/classes/http%253A%252F%252Fpurl.obolibrary.org%252Fobo%252FCL_0000706)</td>
</tr>
<tr>
<td class="label">Database</td>
<td>ID</td>
</tr>
<tr>
<td class="label">Cell Ontology</td>
<td>[CL:0000706](https://www.ebi.ac.uk/ols4/ontologies/cl/classes/http%253A%252F%252Fpurl.obolibrary.org%252Fobo%252FCL_0000706)</td>
</tr>
<tr>
<td class="label">Cell Ontology</td>
<td>[CL:4301608](https://www.ebi.ac.uk/ols4/ontologies/cl/classes/http%253A%252F%252Fpurl.obolibrary.org%252Fobo%252FCL_4301608)</td>
</tr>
<tr>
<td class="label">Cell type</td>
<td>Cuboidal epithelium</td>
</tr>
<tr>
<td class="label">Key markers</td>
<td>AQP1, TTR, transthyretin, claudin-2</td>
</tr>
<tr>
<td class="label">Transporters</td>
<td>P-gp, BCRP, OAT1/3, OCTN2</td>
</tr>
<tr>
<td class="label">Secretory products</td>
<td>CSF, trophic factors, cytokines</td>
</tr>
</table>

Overview

...

Choroid Plexus Epithelial Cells in Neurodegeneration

<table class="infobox infobox-cell">
<tr>
<th class="infobox-header" colspan="2">Choroid Plexus Epithelial Cells in Neurodegeneration</th>
</tr>
<tr>
<td class="label">Taxonomy</td>
<td>ID</td>
</tr>
<tr>
<td class="label">Cell Ontology (CL)</td>
<td>[CL:0000706](https://www.ebi.ac.uk/ols4/ontologies/cl/classes/http%253A%252F%252Fpurl.obolibrary.org%252Fobo%252FCL_0000706)</td>
</tr>
<tr>
<td class="label">Database</td>
<td>ID</td>
</tr>
<tr>
<td class="label">Cell Ontology</td>
<td>[CL:0000706](https://www.ebi.ac.uk/ols4/ontologies/cl/classes/http%253A%252F%252Fpurl.obolibrary.org%252Fobo%252FCL_0000706)</td>
</tr>
<tr>
<td class="label">Cell Ontology</td>
<td>[CL:4301608](https://www.ebi.ac.uk/ols4/ontologies/cl/classes/http%253A%252F%252Fpurl.obolibrary.org%252Fobo%252FCL_4301608)</td>
</tr>
<tr>
<td class="label">Cell type</td>
<td>Cuboidal epithelium</td>
</tr>
<tr>
<td class="label">Key markers</td>
<td>AQP1, TTR, transthyretin, claudin-2</td>
</tr>
<tr>
<td class="label">Transporters</td>
<td>P-gp, BCRP, OAT1/3, OCTN2</td>
</tr>
<tr>
<td class="label">Secretory products</td>
<td>CSF, trophic factors, cytokines</td>
</tr>
</table>

Overview

Choroid Plexus Epithelial Cells In Neurodegeneration plays an important role in the study of neurodegenerative diseases. This page provides comprehensive information about this topic, including its mechanisms, significance in disease processes, and therapeutic implications.

<!-- taxonomy-enrichment -->

<!-- multi-taxonomy-enrichment -->

Multi-Taxonomy Classification

Taxonomy Database Cross-References

PanglaoDB Marker Cross-References

• Unknown (PanglaoDB):

External Database Links

• [Cell Ontology (CL:0000706)](https://www.ebi.ac.uk/ols4/ontologies/cl/classes/http%253A%252F%252Fpurl.obolibrary.org%252Fobo%252FCL_0000706)
• [OBO Foundry (CL:0000706)](http://purl.obolibrary.org/obo/CL_0000706)
• [Allen Brain Cell Atlas](https://portal.brain-map.org/atlases-and-data/bkp/abc-atlas)
• [CellxGene Census](https://cellxgene.cziscience.com/)
• [Human Cell Atlas](https://www.humancellatlas.org/)
• [PanglaoDB](https://panglaodb.se/)

Taxonomy & Classification

PanglaoDB Marker Cross-References

• Unknown (PanglaoDB):

External Database Links

• [Cell Ontology (CL:0000706)](https://www.ebi.ac.uk/ols4/ontologies/cl/classes/http%253A%252F%252Fpurl.obolibrary.org%252Fobo%252FCL_0000706)
• [OBO Foundry (CL:0000706)](http://purl.obolibrary.org/obo/CL_0000706)
• [Allen Brain Cell Atlas](https://portal.brain-map.org/atlases-and-data/bkp/abc-atlas)
• [CellxGene Census](https://cellxgene.cziscience.com/)
• [PanglaoDB](https://panglaodb.se/)

Introduction

The choroid plexus (CP) is a highly vascularized structure located within the brain ventricles, consisting of epithelial cells that produce cerebrospinal fluid (CSF). Choroid plexus epithelial cells (CPECs) form the blood-CSF barrier and are increasingly recognized as important players in neurodegenerative diseases, including Alzheimer's disease (AD), Parkinson's disease (PD), and Multiple System Atrophy (MSA). These cells are affected by neurodegeneration through multiple mechanisms including senescence, inflammation, and impaired function.

Anatomy and Function

Location and Structure

The choroid plexus is found in all four ventricles:

• Lateral ventricles: Temporal horn (largest CP)
• Third ventricle: Roof region
• Fourth ventricle: Roof and lateral apertures

Each CP consists of a core of fenestrated capillaries surrounded by a single layer of cuboidal epithelial cells connected by tight junctions[@johanson2008].

Barrier Function

CPECs form the blood-CSF barrier with several key features:

• Tight junctions: Claudin-1, claudin-2, occludin, ZO-1
• Transporters: P-glycoprotein (P-gp), BCRP, organic anion transporters (OATs)
• Enzymes: Gamma-glutamyl transpeptidase, alkaline phosphatase

CSF Production

CPECs produce approximately 500-600 mL of CSF daily through:

• Active transport: Na+/K+ ATPase on apical membrane
• Aquaporin channels: AQP1 for water transport
• Carbonic anhydrase: CO2 hydration for HCO3- production

Cellular Properties

Transport Functions

CPECs express numerous transporters mediating:

• Drug efflux: P-gp, BCRP limit CNS drug penetration
• Nutrient transport: Amino acid, glucose transporters
• Ion transport: Na+/K+ ATPase, Cl- channels
• Toxin clearance: Organic anion transporters[@strazielle2020]

Role in Neurodegenerative Diseases

Alzheimer's Disease

CP dysfunction in AD contributes to:

CSF hypersecretion: Altered CSF dynamics

Aβ clearance impairment: Reduced Aβ transport across CP

Tau pathology: CP can accumulate neurofibrillary tangles

Inflammation: Pro-inflammatory cytokine production

BBB disruption: Secondary effects on blood-brain barrier

The choroid plexus shows morphological changes in AD including epithelial atrophy, basement membrane thickening, and reduced CSF production[@serot2003].

Parkinson's Disease

CP involvement in PD includes:

• α-Synuclein accumulation: CP can contain Lewy bodies
• Autonomic dysfunction: CP controls CSF volume/pressure
• Drug delivery: P-gp affects levodopa CNS penetration
• Neuroinflammation: CP as source of inflammatory mediators

Multiple System Atrophy

CP pathology in MSA includes:

• Degeneration: Loss of CP epithelial cells
• CSF dynamics: Contributes to autonomic failure
• Inflammation: Gliosis and cytokine production

Amyotrophic Lateral Sclerosis

• CSF alterations: Changed CP function
• Transport changes: Drug delivery challenges
• Inflammation: Pro-inflammatory mediator production

Mechanisms of CP Dysfunction

Cellular Senescence

CPECs undergo senescence in aging and neurodegeneration:

• p16INK4a accumulation: Cell cycle arrest marker
• SASP production: Pro-inflammatory cytokines (IL-6, IL-8)
• Telomere shortening: Replicative senescence
• Oxidative stress: ROS accumulation

Protein Aggregation

CP can accumulate disease-related proteins:

• Aβ: Senile plaques in CP stroma
• Tau: Neurofibrillary tangles
• α-Synuclein: Lewy body-like inclusions

Barrier Breakdown

Neurodegeneration compromises CP barrier function:

• Tight junction disruption: Increased paracellular permeability
• Transporter dysfunction: Impaired drug clearance
• Matrix remodeling: Basement membrane changes[@balusu2016]

Clinical Implications

Diagnostic Biomarkers

CP-derived CSF markers:

• TTR (transthyretin): Decreased in AD
• Aβ1-42: Reduced in CSF with CP dysfunction
• Total tau: Marker of neuronal damage
• Inflammatory cytokines: IL-6, IL-8 elevated

Therapeutic Targets

• P-gp modulators: Improve drug delivery
• Anti-inflammatory agents: Reduce CP inflammation
• Trophic support: Growth factor enhancement
• Regenerative approaches: CP cell replacement

Drug Delivery

Understanding CP function is critical for:

• CNS drug development: P-gp substrate optimization
• BBB/BCSFB targeting: Combined barrier strategies
• Intrathecal delivery: Direct CSF administration

Research Directions

• Single-cell analysis: CP cell heterogeneity
• Organoid models: Human CP in a dish
• Gene therapy: CP-targeted interventions
• Biomarker development: CP-derived disease markers
• [Blood-Brain Barrier](/mechanisms/blood-brain-barrier) Cerebrospinal Fluid Dynamics
• [Alzheimer's Disease](/diseases/alzheimers-disease)
• [Parkinson's Diseas- [Neuroinflammation](/mechanisms/neuroinflammation)sons-disease)
• [Neuroinflammation](/mechanisms/neuroinflammation)

Overview

Choroid Plexus Epithelial Cells In Neurodegeneration plays an important role in the study of neurodegenerative diseases. This page provides comprehensive information about this topic, including its mechanisms, significance in disease processes, and therapeutic implications.

Background

The study of Choroid Plexus Epithelial Cells In Neurodegeneration has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.

Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.

External Links

• [PubMed](https://pubmed.ncbi.nlm.nih.gov/) - Biomedical literature
• [Alzheimer's Disease Neuroimaging Initiative](https://adni.loni.usc.edu/) - Research data
• [Allen Brain Atlas](https://brain-map.org/) - Brain gene expression data

Pathway Diagram

The following diagram shows the key molecular relationships involving Choroid Plexus Epithelial Cells in Neurodegeneration discovered through SciDEX knowledge graph analysis: